Creagene Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Creagene Inc..The latest application filed is for "animal models carrying tumors expressing human liver cancer-specific antigen and method for analyzing prevention and treatment efficacy of dendritic cells-derived immunotherapeutics using the above".

Company Profile

0.5.5

Creagene Inc. - Kyungki-do KR
CREAGENE INC. - Sungman-si KR
CREAGENE INC. - Sungnam-si KR
CREAGENE, INC. - Seoul KR
Creagene, Inc. - Gyeonggi-do KR
Creagene, Inc. - Daejon Metropolitan KR
CreaGene Inc. - KR KR
Creagene Inc. - Taejon KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use of MLN51 gene and protein Grant 8,513,028 - Jang , et al. August 20, 2	2013-08-20
Animal Models Carrying Tumors Expressing Human Liver Cancer-specific Antigen And Method For Analyzing Prevention And Treatment Efficacy Of Dendritic Cells-derived Immunotherapeutics Using The Above App 20100235932 - Bae; Yong-Soo ; et al.	2010-09-16
Pharmaceutical Compositions for Treating Rheumatoid Arthritis Comprising Semi-Mature Dendritic Cell App 20100215624 - Kang; Mi-Sun ; et al.	2010-08-26
Mesenchymal stem cell-mediated autologous dendritic cells with increased immunosuppression App 20100055076 - Lim; Dae Seog ; et al.	2010-03-04
Animal Models Carrying Tumors Expressing Human Prostate Cancer-specific Antigen And Method For Analyzing Prevention And Treatment Efficacy Of Dendritic Cells-derived Immunotherapeutics App 20090293138 - Lee; Dong Sung ; et al.	2009-11-26
Method For Effectively Measuring The Activity Of Cytotoxic T Lymphocytes In Human And Out-bred Animals App 20090029387 - Jung; Sang Won ; et al.	2009-01-29
Advanced oral poliovirus vaccine (Adv-OPV) deprived of the possibility of vaccine associated paralytic poliomyelities (VAPP) Grant 7,138,274 - Bae , et al. November 21, 2	2006-11-21
Cytoplasmic transduction peptides and uses thereof Grant 7,101,844 - Kim , et al. September 5, 2	2006-09-05
Method for improving genetic stability of foreign insert nucleotide sequence in recombinant poliovirus Grant 6,780,618 - Lee , et al. August 24, 2	2004-08-24
Replication-competent recombinant Sabin type 1 strain of poliovirus Grant 6,696,289 - Bae , et al. February 24, 2	2004-02-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.